Clinical trial
Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease
NCT00115336 · Children's Hospital Medical Center, Cincinnati, Other · Terminated
Key facts
| NCT number | NCT00115336 |
|---|---|
| Title | Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease |
| Official title | Ketorolac Versus Ibuprofen for the Painful Crisis of Sickle Cell Disease - Southwestern Comprehensive Sickle Cell Center |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH University of Texas Southwestern Medical Center |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hematologic Diseases, Anemia, Sickle Cell |
| Intervention type | Drug |
| Interventions | Intravenous Ketorolac, Ibuprofen |
| Enrollment | 10 |
| Start date | Jan 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jun 22, 2005 |
| Last update posted | Oct 8, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: